SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 4/29/11 Pure Bioscience, Inc. S-3MEF 4/29/11 3:137K Edgar Tech & Bus… Inc/FA |
Document/Exhibit Description Pages Size 1: S-3MEF Registration of Additional Securities HTML 55K 2: EX-5.1 Opinion re: Legality HTML 35K 3: EX-23.1 Consent of Experts or Counsel HTML 7K
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
Form S-3
|
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
|
PURE BIOSCIENCE, INC.
|
(Exact name of registrant as specified in its charter)
|
Delaware
|
33-0530289
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(I.R.S. Employer Identification No.)
|
PURE Bioscience
1725 Gillespie Way
(619) 596-8600
|
(Address, including zip code, and telephone number, including area code, of Registrant's principal executive offices)
|
President and Chief Executive Officer
1725 Gillespie Way
(619) 596-8600
|
(Name, address, including zip code, and telephone number, including area code, of agent for service)
|
From time to time after the effective date of this Registration Statement.
|
(Approximate date of commencement of proposed sale to the public)
|
Large accelerated filer o
|
Accelerated filer o
|
|
Non-accelerated filer o (Do not check if a smaller reporting company)
|
Smaller reporting company x
|
Title of Each Class of
|
Amount to be
|
Proposed
Maximum
Offering Price
|
Proposed
Maximum
Aggregate Offering
|
Amount of
Registration |
||||||||||
Securities To Be Registered
|
Registered
|
per Unit
|
Price
|
Fee
|
||||||||||
Common Stock, par value $0.01
|
(2) | (3) | (3) | (1) | ||||||||||
Preferred Stock, par value $0.01
|
(2) | (3) | (3) | (1) | ||||||||||
Warrants
|
(2) | (3) | (3) | (1) | ||||||||||
Units
|
(2) | (3) | (3) | (1) | ||||||||||
Total
|
(2) | $1,078,603 | $125.23 (4) | |||||||||||
(1)
|
Calculated pursuant to Rule 457(o) under the Securities Act.
|
(2)
|
There are being registered hereunder such indeterminate number of shares of common stock and preferred stock, such indeterminate number of warrants to purchase common stock and/or preferred stock, and such indeterminate number of units as may be sold by the registrant from time to time, which together shall have an aggregate initial offering price not to exceed $1,078,603. Any securities registered hereunder may be sold separately or as units with the other securities registered hereunder. The proposed maximum offering price per unit will be determined, from time to time, by the registrant in connection with the issuance by the registrant of the securities registered hereunder.
The securities registered hereunder also include such indeterminate number of shares of common stock and preferred stock as may be issued upon conversion of or exchange for preferred stock, upon exercise of warrants or pursuant to the antidilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act, the shares being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
|
(3)
|
Represents only the additional amount of securities being registered. Does not include the securities that the Registrant previously registered on the registration statement on Form S-3 (Registration No. 333-158555).
|
(4)
|
Represents the registration fee only for the additional number of shares being registered. A filing fee of $837 was previously paid for the securities that the Registrant previously registered on the registration statement on Form S-3 (Registration No. 333-158555).
|
Exhibit
Number
|
|
Description of the Document
|
5.1
|
*
|
Opinion of Morrison & Foerster LLP
|
23.1
|
*
|
Consent of Independent Registered Public Accounting Firm
|
23.2
|
*
|
Consent of Morrison & Foerster LLP (contained in Exhibit 5.1)
|
24.1
|
(1)
|
(1)
|
Previously filed on the signature page to the Post Effective Amendment to Form S-3 registration statement, filed with the SEC on March 25, 2011 (SEC File #333-158555).
|
PURE BIOSCIENCE, INC.
|
||
By:
|
/s/ Michael L. Krall
|
|
President, Chairman, Chief Executive Officer (Principal Executive Officer)
Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
||
NAME
|
TITLE
|
DATE
|
||
*
|
Director
|
|
||
Gregory Barnhill
|
||||
*
|
Director
|
|||
Dennis Brovarone
|
||||
*
|
Director
|
|||
John J. Carbone, M.D.
|
||||
*
|
President, Chairman, Director, Chief Executive Officer (Principal Executive Officer) and Interim Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
|
|||
*
|
Director
|
|||
Paul V. Maier
|
||||
*
|
Executive Vice President and Director
|
|||
Donna Singer
|
||||
Exhibit
Number
|
|
Description of the Document
|
5.1
|
*
|
Opinion of Morrison & Foerster LLP
|
23.1
|
*
|
Consent of Independent Registered Public Accounting Firm
|
23.2
|
*
|
Consent of Morrison & Foerster LLP (contained in Exhibit 5.1)
|
24.1
|
(1)
|
(1)
|
Previously filed on the signature page to the Post Effective Amendment to Form S-3 registration statement, filed with the SEC on March 25, 2011 (SEC File #333-158555).
|
This ‘S-3MEF’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / Effective on: | 4/29/11 | 424B5, 8-K | ||
3/30/11 | ||||
3/25/11 | 8-A12B/A, 8-K, POS AM, S-8 POS | |||
5/8/09 | ||||
List all Filings |